Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

CPL PHARMACEUTICALS PRIVATE LIMITED

Active

CPL PHARMACEUTICALS PRIVATE LIMITED having CIN U24299GJ2021PTC119244 is 4 years , 5 month & 6 days old Private Indian Company incorporated on 01 Jan 2021. It is classified as Non-government company and is registered at ROC Ahmedabad. Its authorized share capital is Rs. 1,000,000,000 and its paid up capital is Rs. 802,800,000. It's NIC code is 24299 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Fine Chemicals And Other Chemical Products N.E.C. (Including Anti-Knock Preparations . CPL PHARMACEUTICALS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 08-25-2023. Directors of CPL PHARMACEUTICALS are Amitabha Banerjee and Kamlesh Navaratnalal Shah.

CPL PHARMACEUTICALS ' Corporate Identification Number (CIN) is U24299GJ2021PTC119244 and its registration number is 119244. Users may contact CPL PHARMACEUTICALS on its Email address - secretarial@cadilapharma.co.in Registered address of CPL PHARMACEUTICALS is 709, CADILA CORPORATE CAMPUS-AT BHAT, SARKHEJ-DHOLKA ROAD,,AHMEDABAD,Gujarat,India-382210. Current status of CPL PHARMACEUTICALS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
1,000,000,000

as on 07/06/2025

Paid Up Capital
802,800,000

as on 07/06/2025

Company Age
4 Year, 5 Months
Last Filing with ROC
1 Year, 9 Months

Company Information

CIN U24299GJ2021PTC119244
Company Status Active
Registration Number 119244
Date of Incorporation 01/01/2021
RoC ROC Ahmedabad
Company Age 4 years & 158 days
Authorized Capital ₹ 1000000000
Paid-up capital ₹ 802800000
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Manufacture Of Fine Chemicals And Other Chemical Products N.E.C. (Including Anti-Knock Preparations
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID secretarial@cadilapharma.co.in
Address 709, CADILA CORPORATE CAMPUS-AT BHAT, SARKHEJ-DHOLKA ROAD, AHMEDABAD Gujarat India 382210
Website cadilapharma.co.in
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
MITUL MAESHKUMAR DAVE
01/19/2022 09698848 *****9250H 3 years
Director
RAMESH R CHOKSI
01/27/2023 06636737 2 years
Director
VINOD BHOORCHAND JAIN
01/01/2021 08204721 *****7519C 4 years
Director
AMITABHA BANERJEE
01/19/2022 05152456 *****0669D 3 years
Director
RAJIV RAJIV MODI
08/16/2024 10276899 *****6723E 0 years
Director
KAMLESH NAVARATNALAL SHAH
11/17/2023 10131552 *****0337H 1 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
CPL INFRASTRUCTURE PRIVATE LIMITED
Active
59,66,00,000.00 2 Gujarat
CPL BIOLOGICALS PRIVATE LIMITED
Active
20,00,00,000.00 2 Gujarat
INVERIKA BIORESEARCH PRIVATE LIMITED
Active
8,21,97,480.00 2 Gujarat
KARNAVATI ENGINEERING PRIVATE LIMITED
Amalgamated
3,00,52,500.00 2 Gujarat
REDEFINE LEISURE PRIVATE LIMITED
Active
5,00,000.00 2 Gujarat
LA VIE BIOLOGICALS PRIVATE LIMITED
Active
5,00,000.00 2 Gujarat
IRM ENTERPRISES PRIVATE LIMITED
Active
10,00,000.00 2 Gujarat
CAD VENTURES PRIVATE LIMITED
Active
4,01,00,000.00 2 Gujarat
GIG - IRM GLASS INSULATORS PRIVATE LIMITED
Active
9,71,00,000.00 1 Gujarat
APOLLO CVHF LIMITED
Active
15,00,00,000.00 2 Gujarat
STEMCYTE INDIA THERAPEUTICS PRIVATE LIMITED
Active
9,80,392.00 2 Gujarat
MAGNIFIK LIFESTYLE LLP
Active
0.00 1 -
GOLDEN MYRIAD INVESTMENT MANAGEMENT LLP
Active
0.00 2 -
MUTUALIST SERVICES PRIVATE LIMITED
Active
1,00,000.00 2 Gujarat

Charges on assets

1

Others

No. of Loans: 2

Total Amount: 3,395,500,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Others Iscon cross road, S G Highway, Ahmedabad 1,989,800,000 14 Aug, 2023 - - Open
Others 1,405,700,000 29 Sep, 2022 29 Sep, 2023 - Open

Registered Details

CIN
U24299GJ2021PTC119244
PAN
U24299GJ2021PTC119244
Incorporation
1 years , 6 month
Company Email
secretarial@cadilapharma.co.in
Paid up Capital
₹ 802,800,000
Authorised Capital
₹ 1,000,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Fine Chemicals And Other Chemical Products N.E.C. (Including Anti-Knock Preparations

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Cpl Pharmaceuticals Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Cpl Pharmaceuticals Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Cpl Pharmaceuticals Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Cpl Pharmaceuticals Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Cpl Pharmaceuticals Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Cpl Pharmaceuticals Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Cpl Pharmaceuticals Private Limited

What is CPL PHARMACEUTICALS PRIVATE LIMITED ?

CPL PHARMACEUTICALS PRIVATE LIMITED having CIN U24299GJ2021PTC119244 is 1 years , 6 month old Private Indian Company incorporated with MCA on 17 Nov 2023. CPL PHARMACEUTICALS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Ahmedabad with an Authorized Share Capital of 1,000,000,000 and paid-up capital is 802,800,000.

What is the CIN of CPL PHARMACEUTICALS PRIVATE LIMITED?

CIN of CPL PHARMACEUTICALS PRIVATE LIMITED is U24299GJ2021PTC119244.

Where is CPL PHARMACEUTICALS PRIVATE LIMITED located?

Address of CPL PHARMACEUTICALS PRIVATE LIMITED is 709, cadila corporate campus-at bhat, sarkhej-dholka road,,ahmedabad,gujarat,india-382210,.

Who are the directors of CPL PHARMACEUTICALS PRIVATE LIMITED ?

The company has 12 directors/key management personnel Rushi Sathe,mitul Dave,ramesh Choksi,vinod Jain,ramesh Choksi,amitabha Banerjee,u24299gj2021ptc119244 U24299gj2021ptc119244,mitul Dave,amitabha Banerjee,yash Kumar,rajiv Modi,kamlesh Shah,

What is the contact details of CPL PHARMACEUTICALS PRIVATE LIMITED ?

Email : secretarial@cadilapharma.co.in
Address : 709, CADILA CORPORATE CAMPUS-AT BHAT, SARKHEJ-DHOLKA ROAD, AHMEDABAD Gujarat India 382210

What does CPL PHARMACEUTICALS PRIVATE LIMITED do?

CPL PHARMACEUTICALS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry